compound 3f [Festa et al., 2019]   Click here for help

GtoPdb Ligand ID: 10187

Compound class: Synthetic organic
Comment: Compound 3f is a non-steroidal, selective farnesoid X receptor (FXR) antagonist with a novel 3,5-disubstituted oxadiazole chemotype [1]. It is proposed as a promising lead that is suitable to further the investigation of the therapeutic value of FXR antagonists in the treatment of cholestasis and related metabolic disorders. Antagonist binding to FXR renders the receptor unable to recruit the coactivators it requires for transcriptional activation, and results instead in transcriptional silencing of FXR target genes. 3f exhibits no agonistic activity toward FXR.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 1
Rotatable bonds 2
Topological polar surface area 50.95
Molecular weight 279.14
XLogP 3.47
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES N1CCC(CC1)c1onc(n1)c1ccc2c(c1)cccc2
Isomeric SMILES N1CCC(CC1)c1onc(n1)c1ccc2c(c1)cccc2
InChI InChI=1S/C17H17N3O/c1-2-4-14-11-15(6-5-12(14)3-1)16-19-17(21-20-16)13-7-9-18-10-8-13/h1-6,11,13,18H,7-10H2
InChI Key PPCNFLPYHQIYHP-UHFFFAOYSA-N
References
1. Festa C, Finamore C, Marchianò S, Di Leva FS, Carino A, Monti MC, Del Gaudio F, Ceccacci S, Limongelli V, Zampella A et al.. (2019)
Investigation around the Oxadiazole Core in the Discovery of a New Chemotype of Potent and Selective FXR Antagonists.
ACS Med Chem Lett, 10 (4): 504-510. DOI: 10.1021/acsmedchemlett.8b00534 [PMID:30996787]